MedPath

The Relationship Between Arsenic Methylation Capability and Blood Metals in Children With Developmental Delays

Completed
Conditions
Developmental Delays
Interventions
Other: study group
Registration Number
NCT02523989
Lead Sponsor
Taipei Medical University
Brief Summary

The purpose of this study is to explore the relationship between arsenic methylation and blood metals in children with developmental delays and its correlation with health related quality of life.

Detailed Description

The investigators recruited children with developmental delays and children with normal development from Shin-Kong Ho-Su Memorial Hospital as controls. Information obtained from the interview included socioeconomic and basic demographic characteristics as well as children function, health condition, and quality of life. On the other hand, blood and urine samples of the participants were collected for the analysis of arsenic methylation related enzymes using polymerase chain reaction and restriction fragment length polymorphism. 2 ml blood were digested for the determination of mercury, lead and arsenic. The relationship between arsenic methylation and blood metals in children with developmental delays and its correlation with health related quality of were analyzed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
137
Inclusion Criteria
  • children with developmental delays obtained written informed consent from parents
Exclusion Criteria
  • parents refused for participation of their children to the intervention failed to obtain the written informed consent from parents

Control group:

Inclusion Criteria:

  • children with normal development obtained written informed consent from parents

Exclusion Criteria:

  • parents refused for participation of their children to the intervention failed to obtain the written informed consent from parents

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
study groupstudy groupchildren confirmed to have developmental delays
control groupstudy groupchildren with typical development
Primary Outcome Measures
NameTimeMethod
heavy metal assessment3 months

laboratory analysis

Secondary Outcome Measures
NameTimeMethod
quality of life2 weeks

questionnaires analysis

Trial Locations

Locations (1)

Shin Kong Wu Ho-Su Memorial Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath